Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-15 5:04 pm Purchase |
2025-03-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BlackRock Portfolio Management LLC | 2,329,827 6.100% |
2,329,827 (New Position) |
Filing History |
| 2025-02-14 4:00 pm Sale |
2024-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
TANG CAPITAL MANAGEMENT LLC | 221,716 0.600% |
-2,186,084 (-90.79%) |
Filing History |
| 2024-11-21 8:27 pm Purchase |
2024-11-14 | 13G | iTeos Therapeutics, Inc. ITOS |
BIOTECHNOLOGY VALUE FUND L P | 2,325,000 6.400% |
1,065,524 (+84.60%) |
Filing History |
| 2024-11-19 09:57 am Unchanged |
2024-11-14 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital Management LLC | 1,020,052 2.800% |
0 (Unchanged) |
Filing History |
| 2024-11-18 9:57 pm Purchase |
2024-11-14 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital Management LLC | 1,020,052 2.800% |
1,020,052 (New Position) |
Filing History |
| 2024-11-14 6:04 pm Sale |
2024-09-30 | 13G | iTeos Therapeutics, Inc. ITOS |
EcoR1 Capital LLC | 1,608,616 4.400% |
-336,056 (-17.28%) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | iTeos Therapeutics, Inc. ITOS |
BLACKROCK INC BLK |
3,882,549 10.600% |
0 (Unchanged) |
Filing History |
| 2024-10-21 4:11 pm Sale |
2024-09-30 | 13G | iTeos Therapeutics, Inc. ITOS |
BLACKROCK INC BLK |
3,882,549 10.600% |
-379,196 (-8.90%) |
Filing History |
| 2024-10-15 9:49 pm Purchase |
2024-10-10 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital LLC | 3,020,052 8.100% |
73,137 (+2.48%) |
Filing History |
| 2024-10-15 7:20 pm Unchanged |
2024-10-10 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Asset Management Inc. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-09-30 09:00 am Purchase |
2024-09-26 | 13G | iTeos Therapeutics, Inc. ITOS |
TANG CAPITAL MANAGEMENT LLC | 2,407,800 6.600% |
2,407,800 (New Position) |
Filing History |
| 2024-05-15 08:37 am Purchase |
2024-05-10 | 13D | iTeos Therapeutics, Inc. ITOS |
Boxer Capital LLC | 2,946,915 8.100% |
792,857 (+36.81%) |
Filing History |
| 2024-05-14 9:10 pm Sale |
2024-05-10 | 13D | iTeos Therapeutics, Inc. ITOS |
RA Capital Management, L.P. | 3,659,046 9.990% |
-758,213 (-17.16%) |
Filing History |
| 2024-02-16 12:54 pm Purchase |
2024-02-05 | 13G | iTeos Therapeutics, Inc. ITOS |
EcoR1 Capital LLC | 1,944,672 5.400% |
1,944,672 (New Position) |
Filing History |
| 2024-02-14 09:45 am Sale |
2023-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BIOTECHNOLOGY VALUE FUND L P | 1,259,476 3.500% |
-551,359 (-30.45%) |
Filing History |
| 2024-02-13 5:08 pm Sale |
2023-12-29 | 13G | iTeos Therapeutics, Inc. ITOS |
The Vanguard Group | 1,490,942 4.170% |
-328,088 (-18.04%) |
Filing History |
| 2024-01-23 4:13 pm Sale |
2023-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
BLACKROCK INC BLK |
4,261,745 11.900% |
-217,676 (-4.86%) |
Filing History |
| 2024-01-09 4:26 pm Sale |
2023-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
MILLENNIUM MANAGEMENT LLC | 967,402 2.700% |
-1,123,431 (-53.73%) |
Filing History |
| 2023-10-24 4:12 pm Purchase |
2023-10-17 | 13G | iTeos Therapeutics, Inc. ITOS |
MILLENNIUM MANAGEMENT LLC | 2,090,833 5.800% |
2,090,833 (New Position) |
Filing History |
| 2023-02-14 10:08 am Sale |
2022-12-31 | 13G | iTeos Therapeutics, Inc. ITOS |
RTW Investments, LP | 0 0.000% |
-2,353,015 (Position Closed) |
Filing History |